跳至主要内容
临床试验/ACTRN12623000430639
ACTRN12623000430639尚未招募4 期

Can measures to reduce GER, including sleeping posture (elevation of the head of the bed) and use of protein pump inhibitors medication, reduce levels of pepsin in exhaled breath condensate (EBC) of people with GER

Mater Misericordiae LTD0 个研究点目标入组 20 人开始时间: 2023年4月28日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion Criteria
  • IPF subjects and normal controls demonstrating measurable EBC pepsin.

排除标准

  • Any subject without measurable EBC pepsin. Subjects with previous oesophageal or gastric surgery or those unable to withhold acid suppressive medication or with recent respiratory tract infection (2 weeks) will be excluded

研究者

相似试验